Uveitis Treatment Market

Posted by ahila on May 1st, 2018

Uveitis is the term that describes group of inflammatory diseases that affect eye and produces swelling. Uveitis can reduce sight and may cause vision loss. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, crohn’s disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as rifabutin and moxifloxacin. Uveitis affects uvea, lens, retina, optic nerve, and vitreous. Uveitis can be classified into anterior uveitis, intermediate uveitis, posterior uveitis and pan-uveitis based on part of inflammation.

The main driver for the growth of uveitis market is rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on research and development to develop new drugs, introduction of biologics into the market, fast approval of the drugs are fuelling the market growth of uveitis treatment market. According to the Ocular Immunology and Uveitis Foundation, worldwide 2,359,242 people are estimated to have the disorder. Even there are significant advances in research and therapeutics, prevalence of blindness secondary to uveitis has not been reduced in the past thirty years. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure are hindering the uveitis treatment system market.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Uveitis treatment market segmented based on drug class, disease type, by cause and distribution channel

Based on drug class, uveitis treatment market is segmented into

• Corticosteroids
• Immunosuppressant
• Monoclonal antibodies
• Antibiotics
• Antivirals
• Antifungal
• Analgesics

Based on disease type, uveitis treatment market is segmented into

• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Panuveitis

Based on cause, uveitis treatment market is segmented into

• Infectious Uveitis
• Non-Infectious Uveitis

Based on distribution channel, uveitis treatment market is segmented into

• Hospital Pharmacies
• Retail Pharmacies
• Others

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/#ulp-c654SbFYO64MsOhu